U.S. markets closed

Mountain Valley MD Holdings Inc. (MVMDF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0831+0.0031 (+3.88%)
At close: 10:32AM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0800
BidN/A x N/A
AskN/A x N/A
Day's Range0.0750 - 0.0831
52 Week Range0.0550 - 0.6520
Avg. Volume38,560
Market Cap28.032M
Beta (5Y Monthly)-0.60
PE Ratio (TTM)N/A
EPS (TTM)-0.0350
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for MVMDF

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    Analyst Report: APA CorporationAPA Corp. is the holding company for Apache Corp., an E&P company with operations in the United States, Egypt and the United Kingdom. It holds a majority interest in Altus Midstream, which, through its consolidated subsidiaries, operates gathering, processing and transmission assets in West Texas and holds equity ownership in four Permian-to-Gulf Coast pipelines.
    Fair Value
    Economic Moat
    6 days agoArgus Research
View more
  • GlobeNewswire

    Mountain Valley MD Holdings Provides Business Update

    TORONTO, April 28, 2022 (GLOBE NEWSWIRE) -- Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTCQX: MVMDF) (FRA: 20MP) is pleased to provide a business update on its technologies and key initiatives. KEY TECHNOLOGIES: MVMD’s primary technologies are being developed with the objective to improve the administration, efficacy and safety of new and existing medicines, therapies, and nutraceuticals. The Company’s Quicksome™ desiccation technology utilizes advanced liposomal tec

  • GlobeNewswire

    Mountain Valley MD Holdings Appoints Dr. Elizabeth Norton to Advisory Role to Support Key Quicksome™ Vaccine and Cold Chain Projects

    TORONTO, March 16, 2022 (GLOBE NEWSWIRE) -- Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTCQX: MVMDF) (FRA: 20MP) is pleased to announce the appointment of Dr. Elizabeth Norton to an advisory position to support MVMD’s key Quicksome™ vaccine and cold chain projects. Dr. Norton is an immunologist with 20 years of experience in evaluating immunity, vaccines, and microbial infections. She has a public health and research background with a current faculty appointment in t

  • GlobeNewswire

    Mountain Valley MD Holdings Announces Restricted Share Unit Plan, RSU Grant and Stock Option Grant

    TORONTO, Jan. 28, 2022 (GLOBE NEWSWIRE) -- Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTCQX: MVMDF) (FRA: 20MP) announces the adoption of a restricted share unit plan (the "RSU Plan"), a grant of restricted share units pursuant to the RSU Plan (each, an "RSU") and the grant of stock options pursuant to its existing stock option plan (the “Stock Option Plan”). “We continue to leverage option and share-based compensation levers in an effort to fully align our team’s ef